Correction: Measuring sustainability of opioid agonist therapy programs in the context of transition from Global Fund Support
Raminta Stuikyte, Ivan Varentsov, Catherine Cook, Sergii Dvoriak

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOpioid Use Disorder Treatment · Global Health and Surgery · Health Systems, Economic Evaluations, Quality of Life
Correction: Harm Reduction Journal (2024) 21:7 10.1186/s12954-024-00931-0
Following publication of the original article [1], the title was incorrectly given as “Measuring sustainability of opioid agonist therapy programs in the context of transition from global fund support” but should have been “Measuring sustainability of opioid agonist therapy programs in the context of transition from Global Fund support”.
The original article has been corrected.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
